Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Anika Therapeutics
ANIK
$283M
| $17.6M | 0.02% |
595,529
-40,988
| -6% | -$1.17M |
|
777
Autoliv
ALV
$8.89B
| $17.6M | 0.02% |
+229,400
| New | +$18.3M |
|
778
Adobe
ADBE
$108B
| $17.5M | 0.02% |
52,137
-398,696
| -88% | -$128M |
|
779
Norwegian Cruise Line
NCLH
$8.98B
| $17.5M | 0.02% |
+1,433,300
| New | +$21.6M |
|
780
Yelp
YELP
$1.32B
| $17.5M | 0.02% |
641,600
+17,000
| +3% | +$539K |
|
781
Kulicke & Soffa
KLIC
$5.01B
| $17.5M | 0.02% |
396,128
-57,829
| -13% | -$2.54M |
|
782
Assurant
AIZ
$13.9B
| $17.5M | 0.02% |
140,100
+137,440
| +5,167% | +$18.3M |
|
783
LSB Industries
LXU
$711M
| $17.5M | 0.02% |
1,315,889
-264,013
| -17% | -$3.94M |
|
784
Teledyne Technologies
TDY
$31.2B
| $17.5M | 0.02% |
43,727
-71,900
| -62% | -$28M |
|
|
SAND
785
DELISTED
Sandstorm Gold
SAND
| $17.5M | 0.02% |
3,323,700
+477,100
| +17% | +$2.44M |
|
786
Brookdale Senior Living
BKD
$3B
| $17.4M | 0.02% |
6,391,602
-618,500
| -9% | -$2.31M |
|
787
Artesian Resources
ARTNA
$369M
| $17.4M | 0.02% |
297,411
-21,700
| -7% | -$1.14M |
|
788
Immunocore
IMCR
$1.74B
| $17.4M | 0.02% |
305,100
+210,300
| +222% | +$11.8M |
|
789
Mid-America Apartment Communities
MAA
$15.6B
| $17.4M | 0.02% |
110,849
-340,000
| -75% | -$53M |
|
790
Gildan
GIL
$10.6B
| $17.3M | 0.02% |
633,000
+33,100
| +6% | +$961K |
|
791
Columbia Financial
CLBK
$1.22B
| $17.3M | 0.02% |
802,032
-66,300
| -8% | -$1.42M |
|
792
QCR Holdings
QCRH
$1.75B
| $17.3M | 0.02% |
348,672
-9,199
| -3% | -$474K |
|
793
Bilibili
BILI
$7.14B
| $17.3M | 0.02% |
730,166
+602,566
| +472% | +$9.59M |
|
794
Carlyle Group
CG
$18.3B
| $17.3M | 0.02% |
579,500
-581,100
| -50% | -$16.6M |
|
795
Applied Industrial Technologies
AIT
$13.2B
| $17.3M | 0.02% |
137,050
+8,500
| +7% | +$1.04M |
|
|
VMEO
796
DELISTED
Vimeo
VMEO
| $17.3M | 0.02% |
5,033,600
+737,710
| +17% | +$2.85M |
|
797
SouthState Bank Corp
SSB
$10.8B
| $17.3M | 0.02% |
226,037
+147,100
| +186% | +$12.3M |
|
798
Camtek
CAMT
$8.06B
| $17.2M | 0.02% |
784,040
-23,500
| -3% | -$542K |
|
|
DVAX
799
DELISTED
Dynavax Technologies
DVAX
| $17.1M | 0.02% |
1,610,651
+545,300
| +51% | +$6.34M |
|
800
Cleveland-Cliffs
CLF
$6.93B
| $17.1M | 0.02% |
1,063,059
-2,442,882
| -70% | -$36.8M |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.